Dr Steve Harland is a Consultant Medical Oncologist based at University College London Hospitals NHS Foundation Trust.

Dr Harland trained in medical oncology at the Royal Marsden Hospital following 3 years of research on clinical pharmacology (Hammersmith Hospital) and biochemical pharmacology (Institute of Cancer Research, Sutton). His MD thesis was on mechanisms of resistance to chemotherapy in human tumours. He worked as a senior lecturer in medical oncology for a year in Glasgow before being appointed to the Institute of Urology, UCL

Dr Harland was appointed Senior Lecturer in Medical Oncology at the Institute of Urology in 1986. Since then he has specialised in testis, bladder and prostate cancers and has led on the medical oncological treatment of these tumours at Middlesex and University College Hospitals. 

He has served as Chairman of the MRC Bladder Cancer Group, of the North London Urology Tumour Board and he continues to chair the Castration-resistant Subgroup of the National Cancer Research Network Prostate Cancer Clinical Studies Group. He was on the Editorial Committee of the Government’s document for improving outcomes in urological cancer. He frequently speaks at International meetings.